These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7006679)

  • 1. Development of quantitative methods of measuring antifungal drug effects in the rabbit cornea.
    Oji EO
    Br J Ophthalmol; 1981 Feb; 65(2):89-96. PubMed ID: 7006679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of econazole in the management of oculomycosis.
    Oji EO; Clayton YM
    Int Ophthalmol; 1982 Feb; 4(3):137-42. PubMed ID: 7068331
    [No Abstract]   [Full Text] [Related]  

  • 3. Clotrimazole and bifonazole in the topical treatment of Candida keratitis in rabbits.
    Behrens-Baumann W; Klinge B; Uter W
    Mycoses; 1990; 33(11-12):567-73. PubMed ID: 2103595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies in experimental keratomycosis.
    O'Day DM
    Curr Eye Res; 1985 Mar; 4(3):243-52. PubMed ID: 4017624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of subconjunctival miconazole in the treatment of experimental Candida keratitis in rabbits.
    Ishibashi Y; Kaufman HE
    Arch Ophthalmol; 1985 Oct; 103(10):1570-3. PubMed ID: 3901987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antifungal agents in the cornea. IV. Amphotericin B methyl ester.
    O'Day DM; Ray WA; Head WS; Robinson RD
    Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):851-4. PubMed ID: 6735649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the corneal epithelium on the efficacy of topical antifungal agents.
    O'Day DM; Ray WA; Head WS; Robinson RD
    Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):855-9. PubMed ID: 6329991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of experimental endogenous Candida albicans endophthalmitis.
    Jones DB
    Trans Am Ophthalmol Soc; 1980; 78():846-95. PubMed ID: 6266113
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of miconazole in experimental keratomycosis.
    Gupta SK
    Aust N Z J Ophthalmol; 1986 Nov; 14(4):373-6. PubMed ID: 3814426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous miconazole therapy for experimental keratomycosis in rabbits.
    Ishibashi Y; Matsumoto Y
    Sabouraudia; 1985 Feb; 23(1):55-61. PubMed ID: 3992428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of extemporaneously prepared miconazole eye drops in Candida albicans-induced keratomycosis.
    Gyanfosu L; Koffuor GA; Kyei S; Ababio-Danso B; Peprah-Donkor K; Nyansah WB; Asare F
    Int Ophthalmol; 2018 Oct; 38(5):2089-2100. PubMed ID: 28900810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketoconazole: a new imidazole antifungal agent has both prophylactic potential and therapeutic efficacy in keratomycosis of rabbits.
    Oji EO
    Int Ophthalmol; 1982 Nov; 5(3):163-7. PubMed ID: 6295973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antifungal agents in the cornea. I. A comparative study.
    O'Day DM; Robinson R; Head WS
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1098-102. PubMed ID: 6874272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally administered antifungal therapy for experimental keratomycosis.
    O'Day DM
    Trans Am Ophthalmol Soc; 1990; 88():685-725. PubMed ID: 2095036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy.
    Onyewu C; Afshari NA; Heitman J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3963-5. PubMed ID: 16923949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal.
    Khadka S; Sherchand JB; Pokhrel BM; Parajuli K; Mishra SK; Sharma S; Shah N; Kattel HP; Dhital S; Khatiwada S; Parajuli N; Pradhan M; Rijal BP
    BMC Res Notes; 2017 Jun; 10(1):218. PubMed ID: 28646915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
    O'Day DM; Ray WA; Robinson R; Head WS
    Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):331-5. PubMed ID: 6321389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of topical clotrimazole in human keratomycosis.
    Mselle J
    Ophthalmologica; 2001; 215(5):357-60. PubMed ID: 11528261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
    Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B
    Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact lens-induced infection--a new model of Candida albicans keratitis.
    O'Day DM; Head WS; Robinson RD; Yang R; Shetlar D; Wang MX
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1607-11. PubMed ID: 10359345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.